Trial · NCT01106625
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Core Period: Baseline to Week 26 | STARTED | Placebo | 156 | |
| Core Period: Baseline to Week 26 | STARTED | Canagliflozin 100 mg | 157 | |
| Core Period: Baseline to Week 26 | STARTED | Canagliflozin 300 mg | 156 | |
| Core Period: Baseline to Week 26 | COMPLETED | Placebo | 123 | |
| Core Period: Baseline to Week 26 | COMPLETED | Canagliflozin 100 mg | 129 | |
| Core Period: Baseline to Week 26 | COMPLETED | Canagliflozin 300 mg | 129 | |
| Core Period: Baseline to Week 26 | NOT COMPLETED | Placebo | 33 | |
| Core Period: Baseline to Week 26 | NOT COMPLETED | Canagliflozin 100 mg | 28 | |
| Core Period: Baseline to Week 26 | NOT COMPLETED | Canagliflozin 300 mg | 27 | |
| Extension Period: Week 26 to Week 52 | STARTED | Placebo | 119 | |
| Extension Period: Week 26 to Week 52 | STARTED | Canagliflozin 100 mg | 127 | |
| Extension Period: Week 26 to Week 52 | STARTED | Canagliflozin 300 mg | 128 | |
| Extension Period: Week 26 to Week 52 | COMPLETED | Placebo | 90 | |
| Extension Period: Week 26 to Week 52 | COMPLETED | Canagliflozin 100 mg | 109 | |
| Extension Period: Week 26 to Week 52 | COMPLETED | Canagliflozin 300 mg | 111 | |
| Extension Period: Week 26 to Week 52 | NOT COMPLETED | Placebo | 29 | |
| Extension Period: Week 26 to Week 52 | NOT COMPLETED | Canagliflozin 100 mg | 18 | |
| Extension Period: Week 26 to Week 52 | NOT COMPLETED | Canagliflozin 300 mg | 17 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01106625/flow